Stay updated with breaking news from Brain Scientific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- DelveInsight's Neurological Diagnostic and Monitoring Equipment Market Insights and Forecast report provide the current and forecast...
- Neurological Diagnostic and Monitoring Equipment market is increasing owing to the prevalence of neurological conditions such as Acute Spinal Cord Injury, Alzheimer's Disease, growing incidence
Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Brain Scientific Files Its Annual Report on Form 10-K Announcing 2020 Results Brain Scientific Inc.April 19, 2021 GMT NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF) (the “Company” or “Brain Scientific”), a neurology-focused medical device and software company, filed its Annual Report on Form 10-K for the fiscal year ended Dec. 31, 2020, with the U.S. Securities and Exchange Commission (SEC). Brain Scientific is a neurodiagnostic and pred...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology EhaveApril 16, 2021 GMT MIAMI, April 16, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to launch brain mapping ketamine clinical trials using Brain Scientific technology later this year. The clinical trial will establish the statistical correlation between the ketamin...